respiratory syncytial virus – Global Health Press

GHP News Latest Science

The economic and clinical impact of RSV in older adults

Respiratory syncytial virus (RSV) poses a significant health risk to individuals aged 60 years and older, often leading to severe acute respiratory infections (ARIs) that result in hospitalizations and substantial...

3 March, 2025

4 min read

GHP News Latest Science

High levels of RSV cases highlight need for greater vaccine awareness

Respiratory syncytial virus (RSV) cases have reached alarming levels across the United States, with several states reporting “very high” activity according to CDC wastewater testing. This surge underscores...

10 January, 2025

4 min read

GHP News Latest Science

RSV vaccination in older adults with health conditions is cost-effective

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study. RSV infections cause...

16 September, 2024

3 min read

GHP News

Catch me if you can: how three infectious disease agents evade the immune system

NTU researchers are understanding how the respiratory syncytial virus, Chikungunya virus and malaria parasite escape being detected by the immune system. COVID-19 cast a glaring spotlight on the devastating impact that...

7 December, 2023

6 min read

GHP News Latest Science

CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth

Today, CDC recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborn from severe RSV illness. RSV is the leading cause of hospitalization for U.S. infants. This new...

23 September, 2023

2 min read

Latest Science

Preparing for coming RSV, influenza epidemics

Large populations are susceptible to respiratory diseases because of COVID-19 intervention policies but reinstating nonpharmaceutical interventions at the correct time can help slow the spread Governments around the...

19 January, 2023

3 min read

Latest Science

Vaccine with virus-like nanoparticles found to be effective treatment for respiratory syncytial virus (RSV)

Researchers at Georgia State University say their findings, published July 14 in the International Journal of Nanomedicine, suggest their nano-engineered vaccine induces long-term protection against respiratory...

18 October, 2022

6 min read

Latest Science

Dreaming up new proteins, AI churns out possible medicines and vaccines

Computational biologist Jue Wang was already striving to develop an artificial intelligence (AI) to churn out candidate medicines when he had to rush his 2-year-old son to the hospital with a potentially lethal...

28 July, 2022

5 min read

Latest Science

Respiratory virus ‘kills 100,000 children under five’

Respiratory syncytial virus (RSV) is common cause of infections such as pneumonia. Most cases and deaths in young children occur in lower-income countries. Passive immunisation campaign urged for babies under six months...

10 June, 2022

4 min read

Latest Science

How COVID-19 created dramatic changes in a ‘winter virus’

The pandemic is changing the genetic landscape of virus strains A University of Sydney- led study reveals how the pandemic has changed the normal patterns of winter viruses in Australia, with new strains emerging and...

1 June, 2022

5 min read

Tag - respiratory syncytial virus